The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AMBRX BIOPHARMA INC | COM | 641871108 | 237,646,177 | 16,688,636 | SH | SOLE | 16,688,636 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 50,094,000 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
KEROS THERAPEUTICS INC | COM | 492327101 | 42,162,578 | 1,060,427 | SH | SOLE | 1,060,427 | 0 | 0 | ||
MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 62,762,663 | 1,039,289 | SH | SOLE | 1,039,289 | 0 | 0 | ||
NUVALENT INC | COM | 670703107 | 4,245,996 | 57,698 | SH | SOLE | 57,698 | 0 | 0 | ||
SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 7,034,791 | 192,734 | SH | SOLE | 192,734 | 0 | 0 | ||
TG THERAPEUTICS INC | COM | 88322Q108 | 69,115,894 | 4,046,598 | SH | SOLE | 4,046,598 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 36,421,425 | 579,959 | SH | SOLE | 579,959 | 0 | 0 |